REVLIS

Since its establishment in 2003, Revlis Biotech Co., Ltd. has been committed to the development of digital health management. Through unique sensors and big data databases, it can measure a variety of physiological indexes originating from ECG, such as blood glucose, glycosylated hemoglobin, blood pressure, heart rate, etc. Among them, non-invasive blood glucose measurement is Revlis' innovative and leading technology... We provide an overall solution that includes smart terminal device/modules, SaaS service model and AI calculation engine. Its advantage lies in the modular architecture of software / hardware design, which can give partners more diversified and flexible applications, reduce entry barriers, and provide customized integrated development and sales services... We provide various health status indicators based on data and AI analysis, which can effectively help users improve the effectiveness of health management, and provide sustainable, high-accuracy, and low-burden..

Also known as: Revlis Biotech Co., Ltd., Revlis Biotech Company Limited

Primary location: Taipei Taiwan